Australia's most trusted
source of pharma news
Posted 24 November 2021 AM
The Department of Industry, Science, Energy and Resources says it "sincerely apologises" to Noxopharm, which is currently weighing up taking legal action after it was incorrectly notified that it was a recipient of one of the largest Australian Government grants ever awarded to a biotech for a single drug program.
A spokesperson from the Department confirmed that the Sydney-based pharma was notified early November that it was the recipient of a $8.79 million grant for a sarcoma trial investigating its chemo-enhancing drug Veyonda.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.